Regulation of Immune Responses by mTOR

被引:643
作者
Powell, Jonathan D. [1 ]
Pollizzi, Kristen N. [1 ]
Heikamp, Emily B. [1 ]
Horton, Maureen R. [2 ]
机构
[1] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21231 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21231 USA
来源
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 | 2012年 / 30卷
关键词
CD4; CD8; Tregs; antigen-presenting cells; B cells; metabolism; CELL-CYCLE PROGRESSION; PLASMACYTOID DENDRITIC CELLS; TYPE-1; DIABETIC-PATIENTS; CD8(+) T-CELLS; MAMMALIAN TARGET; CUTTING EDGE; IN-VIVO; B-CELLS; PROTEIN-KINASE; TRANSLATIONAL CONTROL;
D O I
10.1146/annurev-immunol-020711-075024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
mTOR is an evolutionarily conserved serine/threonine kinase that plays a central role in integrating environmental cues in the form of growth factors, amino acids, and energy. In the study of the immune system, mTOR is emerging as a critical regulator of immune function because of its role in sensing and integrating cues from the immune microenvironment. With the greater appreciation of cellular metabolism as an important regulator of immune cell function, mTOR is proving to be a vital link between immune function and metabolism. In this review, we discuss the ability of mTOR to direct the adaptive immune response. Specifically, we focus on the role of mTOR in promoting differentiation, activation, and function in T cells, B cells, and antigen-presenting cells.
引用
收藏
页码:39 / 68
页数:30
相关论文
共 171 条
[1]   Immunopharmacology of rapamycin [J].
Abraham, RT ;
Wiederrecht, GJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :483-510
[2]   Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling [J].
Abraham, RT .
CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (03) :330-336
[3]   The novel cyclophilin binding compound, sanglifehrin A, disassociates G1 cell cycle arrest from tolerance induction [J].
Allen, A ;
Zheng, Y ;
Gardner, L ;
Safford, M ;
Horton, MR ;
Powell, JD .
JOURNAL OF IMMUNOLOGY, 2004, 172 (08) :4797-4803
[4]   Rapamycin generates anti-apoptotic human Th1/Tc1 cells via autophagy for induction of xenogeneic GVHD [J].
Amarnath, Shoba ;
Flomerfelt, Francis A. ;
Costanzo, Carliann M. ;
Foley, Jason E. ;
Mariotti, Jacopo ;
Konecki, Daniel M. ;
Gangopadhyay, Anu ;
Eckhaus, Michael ;
Wong, Susan ;
Levine, Bruce L. ;
June, Carl H. ;
Fowler, Daniel H. .
AUTOPHAGY, 2010, 6 (04) :523-541
[5]   The role of mTOR in memory CD8+T-cell differentiation [J].
Araki, Koichi ;
Youngblood, Ben ;
Ahmed, Rafi .
IMMUNOLOGICAL REVIEWS, 2010, 235 :234-243
[6]   mTOR regulates memory CD8 T-cell differentiation [J].
Araki, Koichi ;
Turner, Alexandra P. ;
Shaffer, Virginia Oliva ;
Gangappa, Shivaprakash ;
Keller, Susanne A. ;
Bachmann, Martin F. ;
Larsen, Christian P. ;
Ahmed, Rafi .
NATURE, 2009, 460 (7251) :108-U124
[7]   LFA-1-specific therapy prolongs allograft survival in rhesus macaques [J].
Badell, Idelberto R. ;
Russell, Maria C. ;
Thompson, Peter W. ;
Turner, Alexandra P. ;
Weaver, Tim A. ;
Robertson, Jennifer M. ;
Avila, Jose G. ;
Cano, Jose A. ;
Johnson, Brandi E. ;
Song, Mingqing ;
Leopardi, Frank V. ;
Swygert, Sarah ;
Strobert, Elizabeth A. ;
Ford, Mandy L. ;
Kirk, Allan D. ;
Larsen, Christian P. .
JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (12) :4520-4531
[8]   Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin [J].
Basu, Samik ;
Golovina, Tatiana ;
Mikheeva, Tatiana ;
June, Carl H. ;
Riley, James L. .
JOURNAL OF IMMUNOLOGY, 2008, 180 (09) :5794-5798
[9]   Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells [J].
Battaglia, M ;
Stabilini, A ;
Roncarolo, MG .
BLOOD, 2005, 105 (12) :4743-4748
[10]   Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients [J].
Battaglia, Manuela ;
Stabilini, Angela ;
Migliavacca, Barbara ;
Horejs-Hoeck, Jutta ;
Kaupper, Thomas ;
Roncarolo, Maria-Grazia .
JOURNAL OF IMMUNOLOGY, 2006, 177 (12) :8338-8347